These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 7533373

  • 21. Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.
    Neuhaus B, Keck H, Bechstein WO, Blumhardt G, Langrehr JM, Wiens M, Lemmens HP, Lohmann R, Schlag H, Thalmann U.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):587-9. PubMed ID: 8438426
    [No Abstract] [Full Text] [Related]

  • 22. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S, Neuhaus R, Junge G, Klupp J, Theruvat T, Langrehr JM, Settmacher U, Neuhaus P.
    Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
    [Abstract] [Full Text] [Related]

  • 23. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression.
    Schumacher G, Mueller AR, Platz KP, Neuhaus R, Bechstein WO, Becker M, Luck W, Neuhaus P.
    Transplant Proc; 1996 Dec; 28(6):3099-100. PubMed ID: 8962200
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M, Schätzl HM, Zachoval R, Uusi-Oukari M, Lehtovaara P.
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [Abstract] [Full Text] [Related]

  • 28. Usefulness of measurement of serum viral DNA using dot-blot hybridization and polymerase chain reaction in renal transplant patients with hepatitis B-positive viral infection.
    Cheng IK, Ho SK, Fang GX, Chan DT, Lai CL.
    Transplant Proc; 1996 Jun; 28(3):1493-4. PubMed ID: 8658756
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R, Cantarell C, Vargas V, Capdevila L, Lázaro JL, Hidalgo E, Murio E, Margarit C.
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [Abstract] [Full Text] [Related]

  • 33. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis.
    Lerut JP, Donataccio M, Ciccarelli O, Roggen F, Jamart J, Laterre PF, Cornu C, Mazza D, Hanique G, Rahier J, Geubel AP, Otte JB.
    J Hepatol; 1999 Apr; 30(4):706-14. PubMed ID: 10207814
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
    Murakami Y, Minami M, Daimon Y, Okanoue T.
    J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Anti-IL-2 receptor BT563 versus placebo: a randomized trial for induction therapy after liver transplantation.
    Glanemann M, Langrehr JM, Raakow R, Guckelberger O, Lohmann R, Klupp J, Lobeck H, Schlag H, Keck H, Bechstein WO, Settmacher U, Neuhaus P.
    Transplant Proc; 1998 Aug; 30(5):2159-60. PubMed ID: 9723425
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation.
    Langrehr JM, Schneller A, Guckelberger O, Lohmann R, Neumann U, Jonas S, Klupp J, Settmacher U, Knoop M, Bechstein WO, Neuhaus PJ.
    Transplant Proc; 1998 Jun; 30(4):1439-40. PubMed ID: 9636583
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.